AIRWAY AND PULMONARY TISSUE RESPONSES TO PLATELET-ACTIVATING-FACTOR IN RATS

被引:11
作者
GARCIA, MLB
PAIVA, PSO
DOLHNIKOFF, M
JANCAR, S
SALDIVA, PHN
MARTINS, MA
机构
[1] USP,FAC MED,DEPT PATOL,POLUICAO ATMOSFER LAB,BR-01246 SAO PAULO,BRAZIL
[2] UNIV SAO PAULO,INST CIENCIAS BIOMED,BR-05508 SAO PAULO,BRAZIL
基金
巴西圣保罗研究基金会;
关键词
AIRWAY RESPONSIVENESS; PLATELET-ACTIVATING FACTOR; PULMONARY MECHANICS;
D O I
10.3109/01902149409064381
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
We studied airway and pulmonary tissue responses to platelet-activating factor (PAF) in rats by measuring alveolar pressure with the alveolar capsule technique. We calculated airway resistance (Raw), dynamic elastance (Edyn), and pulmonary tissue resistance (Rtis). PAF was administered intravenously in doses of 0.1, 1, 10, and 30 mu g (1 dose per animal, 5 rats for each dose). Infusion of PAF resulted in a significant increase in Rtis and Edyn (p < .05). Maximal values of Edyn were observed with the infusion of 10 mu g of PAF (p < .02). Rtis presented a significant increase after infusion of 1 mu g of PAF (p < .05). The observed increase in Raw was transient and did not reach statistical significance. After infusion of PAF lungs were fixed by a quick-freezing method. Morphometric analysis showed that PAF infusion resulted in significant increases in intraluminal secretion (p = .001) and peribronchiolar edema (p < .001) but did not result in significant airway contraction. We conclude that intravenous infusion of PAF results in significant effects on lung tissue mechanics. The effects of PAF on the mechanical properties of lung parenchyma reflect the inflammatory alterations induced by this agonist in distal airspaces.
引用
收藏
页码:169 / 184
页数:16
相关论文
共 27 条
[1]  
AGRAWAL DK, 1991, J PHARMACOL EXP THER, V259, P1
[2]   PAF CLOSELY MIMICS PATHOLOGY OF ASTHMA [J].
BARNES, PJ ;
CHUNG, KF .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1987, 8 (08) :285-287
[3]  
BRAQUET P, 1987, PHARMACOL REV, V39, P97
[4]   MODIFICATION OF ALLERGEN-INDUCED AIRWAY-OBSTRUCTION AND AIRWAY HYPERRESPONSIVENESS IN AN ALLERGIC RABBIT MODEL BY THE SELECTIVE PLATELET-ACTIVATING FACTOR ANTAGONIST, BN-52021 [J].
COYLE, AJ ;
PAGE, CP ;
ATKINSON, L ;
SJOERDSMA, K ;
TOUVAY, C ;
METZGER, WJ .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1989, 84 (06) :960-967
[5]  
DYSON MC, 1990, J PHARMACOL EXP THER, V255, P1320
[6]   ON THE IMPERFECT ELASTICITY OF LUNG-TISSUE [J].
FREDBERG, JJ ;
STAMENOVIC, D .
JOURNAL OF APPLIED PHYSIOLOGY, 1989, 67 (06) :2408-2419
[7]  
HOPPIN FG, 1986, HDB PHYSL RESPIRATOR, V3, P195
[8]   DIFFERENTIAL ACTIONS OF PLATELET-ACTIVATING-FACTOR (PAF) RECEPTOR ANTAGONISTS ON THE VASODILATOR AND VASOCONSTRICTOR EFFECTS OF PAF IN THE RAT PERFUSED HEART [J].
HU, WM ;
MAN, RYK .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 104 (04) :773-775
[9]   MECHANISMS OF THE CORONARY VASCULAR EFFECTS OF PLATELET-ACTIVATING-FACTOR IN THE RAT PERFUSED HEART [J].
HU, WM ;
KINNAIRD, AAA ;
MAN, RYK .
BRITISH JOURNAL OF PHARMACOLOGY, 1991, 103 (01) :1097-1102
[10]   LIPID MEDIATORS CONTRIBUTE TO OXYGEN-RADICAL-INDUCED AIRWAY RESPONSES IN SHEEP [J].
LANSING, MW ;
MANSOUR, E ;
AHMED, A ;
CORTES, A ;
GARCIA, L ;
LAUREDO, IT ;
WANNER, A ;
ABRAHAM, WM .
AMERICAN REVIEW OF RESPIRATORY DISEASE, 1991, 144 (06) :1291-1296